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Objectives. The aim of this study was to perform a multiple 
logistic regression analysis to identify independent structural 
determinants of impaired left ventricular function. 
Background. The association between contractile failure and 
structural alterations of the myocardium has been demonstrated 
in several studies, and multiple interactions between myocardial 
structure and cardiac performance are likely. 
Methods. Morphometric data assessed from 130 left ventricu· 
lar biopsy specimens were analyzed. The endomyocardial speci· 
mens were obtained from 57 patients with normal coronary 
arteries (17 with normal left ventricular ejection fraction and 40 
with impaired left ventricular function [dilated cardiomyopathy)), 
15 patients with hypertrophic cardiomyopathy and 32 patients 
with aortic valve disease. Transmural biopsy specimens were 
assessed in 6 donor hearts before heart transplantation and in 20 
patients with left anterior descending coronary artery disease 
whose specimens were obtained from the left ventricular anterior 
The association between contractile failure and structural 
alterations of the myocardium, such as augmented cardiac 
fibrosis and myocyte degeneration, has been demonstrated 
in several studies 0-4). Other investigators (5-8) reported 
significant correlations between left ventricular ejection frac-
tion and the volume density of myofibrils in patients with 
dilated cardiomyopathy (5-7) or aortic valve disease (8). A 
significant interrelation between left ventricular performance 
and myocyte hypertrophy has been shown (9). 
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wall during aortocoronary bypass surgery. Global or regional left 
ventricular function was evaluated from left cineventriculograms. 
The volume fraction of cardiac fibrous tissue, intracellular volume 
fraction of myofibriIs, volume fraction of myofibrils related to 
myocardial tissue (including fibrosis) and myofiber diameters 
were determined from semi thin sections of the biopsy specimens 
with the use of light microscopic morphometry. 
Results. Multiple logistic regression analysis revealed de· 
creased volume fraction of myofibrils (p < 0.005) and increased 
fiber diameter (p < 0.002) as independent determinants of im· 
paired left \"entricular function. 
Conclusions. These data indicate that, independent of the 
underlying heart disease, both decreased concentration of con· 
tractile proteins and myocyte hypertrophy are independently 
associated with impaired left ventricular function. 
a Am Coll CardioI1992;20:1135-42) 
Multiple interactions between myocardial structure and 
cardiac performance have to be anticipated (10). Therefore, 
the purpose of the present study was to identify structural 
determinants of impaired left ventricular function in patients 
with different chronic cardiac disorders, such as dilative or 
hypertrophic cardiomyopathy, aortic valve disease and cor-
onary artery disease. Left ventricular biopsy specimens 
obtained from 124 patients and 6 donor hearts were analyzed 
with standard morphometric methods (11,12) and, for the 
first time, a multiple logistic regression analysis was per-
formed to identify independent determinants of left ventric-
ular function. Other variables· tested in addition to the 
morphometric data and the clinical diagnoses were patient 
gender and age. 
Methods 
Patients. Left ventricular endomyocardial or transmural 
biopsies, respectively, were performed in 124 patients and 6 
normal donor hearts. Informed consent was obtained from 
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all patients; the protocols were approved by the human 
study committees of the Universities of Heidelberg and 
Zurich. 
Patients were classified, according to their clinical diag-
noses, into four groups: 
Group I. These 57 patients (52 male, 5 female with a 
mean age [±SD] of 41 ± 8 years) were studied because of 
persistent but predominantly atypical chest pain or symp-
toms of heart failure, or both. At cardiac catheterization, 
they had normal coronary arteries with either an impaired 
«50%) left ventricular ejection fraction (that is, dilated 
cardiomyopathy, Group la, 40 patients) or a normal (~50%) 
left ventricular ejection fraction (Group Ib, 17 patients). 
Group II. These 15 patients (10 male and 5 female with a 
mean age of 41 ± 10 years) had symptomatic hypertrophic 
cardiomyopathy. Four of these patients had an impaired 
«50%) left ventricular ejection fraction. 
Group III. These 32 patients (17 male and 15 female with 
a mean age of 52 ± 7 years) had aortic valve disease. Twelve 
of these patients had aortic regurgitation (Group IlIa) and 20 
had aortic stenosis (Group IIIb). Four of the 32 patients had 
a decreased «50%) left ventricular ejection fraction. In all 
patients with aortic valve disease, endomyocardial biopsy 
specimens were taken before surgical valve replacement at 
the time of preoperative cardiac catheterization. 
Group IV (coronary heart disease). These 20 patients (19 
male and 1 female, with a mean age of 59 ± 7 years) had 
~75% stenosis of the left anterior descending coronary 
artery. Of these, 11 patients had a history of previous 
anterior myocardial infarction (non-Q wave in 7, Q wave in 
4). In contrast to patients in Groups I to III, each patient in 
Group IV had two transmural biopsy specimens taken from 
the left anterior ventricular wall during coronary artery 
bypass grafting, and the regional left ventricular wall motion 
was assessed in the anterolateral segments by analysis of the 
left ventricular cineangiogram. 
Control group. Morphometric control values were deter-
mined from transmural biopsy specimens obtained before 
cardiac transplantation from six donor hearts (from five male 
patients and one female patient, with a mean age of 31 ± 5 
years). 
Left Yentricular function. Global left ventricular ejection 
fraction (Groups I to III) was determined with the area-
length method (13) from cineventriculograms. A left ventric-
ular ejection fraction ~50% was considered normal. 
Regional wall motion in the anterolateral segments 
(Group IV) was determined with the centerline method from 
left ventriculograms taken in the right anterior oblique view. 
Regional wall motion was considered abnormal if wall mo-
tion was ~2 SD below the mean anterolateral wall motion 
previously obtained from 64 normal patients (14). 
Thus, impaired left ventricular function was defined as 
left ventricular ejection fraction <50% in Groups I to III and 
as abnormal regional wall motion in Group IV. 
Biopsy specimens. Biopsies in Group I and II were per-
formed at the Department of Cardiology, Heidelberg, those 
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in Group III at the Division of Cardiology, Medical Poli-
clinic, Zurich and those in Group IV at the Department of 
Cardiac Surgery, Heidelberg. 
In Groups I to III, two to four left ventricular endomyo-
cardial biopsy specimens were taken from patients at the 
time of cardiac catheterization. In Group IV (patients with 
coronary heart disease), two transmural biopsy specimens 
were taken from the anterior wall of the left ventricle caudal 
to the first diagonal branch during cardiopulmonary bypass 
(before institution of cardioplegia) with the use of a Travenol 
biopsy needle with a lumen diameter of 1.5 mm. 
All tissue samples were immediately fixed with glutaral-
dehyde, postfixed in osmium tetroxide (OS04)' dehydrated 
in ethanol and embedded in Epon. Semithin sections 
(0.5 JLm) were prepared and double-stained with paraphenyl-
enediamine and toluidine blue for the morphometric inves-
tigations (II). 
Morphometry. All morphometric analyses were per-
formed in Heidelberg with standard light microscopy. From 
each section of the biopsy specimens, the volume fraction of 
interstitial fibrosis, the muscle fiber diameters and the intra-
cellular volume fraction of myofibrils were determined. 
Because severe contraction bands of the myofibrils may 
occur artificially with mechanical disruption, only the central 
two thirds of the sections were evaluated. 
The volume fraction of interstitial jibrosis was deter-
mined as previously described (11). We, and others (7,9,12), 
apply the term "interstitial fibrosis" to the interstitial non-
muscular tissue because fibrous tissue represents the pre-
dominant component of the interstitial space (15). Evalua-
tion was performed with an eyepiece (Zeiss Integration) 
containing 100 intersection points. At least lO test areas were 
counted at x 160 magnification. Endomyocardial fibrous 
tissue was thereby carefully excluded from the analysis. 
Interobserver variability was 8.3 vol% and intraobserver 
variability 5.0 vol%. 
At x420 magnification,jiber diameters were measured at 
the shortest diameter from cross or oblique sections at the 
level of the nuclei from all cardiac muscle fibers of the 
section (II) using the semiautomatic image analyzing system 
(Mechanical-Optical Pen). 
The illlracellular volume fraction of myojibrils was eval-
uated by oil immersion and phase contrast (x 1,016 magnifi-
cation) and two randomly chosen test areas per section with 
100 test points were used (II). The intracellular volume 
fraction of myofibrils equals the number of points falling on 
myofibrils divided by points projected on total myocardial 
cells (including myofibrils). Interobserver variability was 5.2 
vol% and intraobserver variability 2.1 vol%. 
Assessment of the volume fraction of a structure by 
point-counting systems permits the quantitative determina-
tion of the volume of this structure (that is, myofibrils) in 
relation to the volume of the entire tissue (that is, the 
intramyocyte space). To determine the volume fraction of 
myofibrils in relation to the total myocardial tissue, a math-
ematical transformation was used according to the equation: 
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Table 1. Hemodynamic Data Obtained in the 124 Study Patients (mean ± 1 SD) 
Patient Clinical LVSP LVEDP PAPmean EF 
Group No. Diagnosis (mmHg) (mmHg) (mm Hg) (%) 
Ia 40 DCM 1I0:!: 18 17.5 :!: 11.4 23.2:!: 5.8 29:!: 16 
Ib 17 123:!: 17 8.4 :!: 3.6 16.9 :!: 4.7 69:!: 12 
II 15 HCM 133 :!: 21 16.7:!: 7.7 21.3 :!: 6.1 64 :!: 12 
IlIa 20 AS 204 :!: 29 17.7:!: 8.2 23.7 :!: 7.3 62:!: II 
IlIb 12 AR 145 :!: 23 17.5 :!: 8.0 22.5 :!: 6.7 63:!: 10 
IV 20 CAD' 120:!: 14 15.3 :!: 6.8 
'Pulmonary pressure and global left ventricular ejection fraction were not determined in patients with coronary 
heart disease (see Methods). AR = aortic regurgitation; AS = aortic stenosis; CAD = coronary artery disease; 
DCM = dilated cardiomyopathy; EF = global left ventricular ejection fraction; Group I = patients with normal 
coronary arteries and either decreased left ventricular ejection fraction (Group la, dilated cardiomyopathy) or normal 
ejection fraction (Group Ib); Group II = patients with hypertrophic cardiomyopathy; Group III = patients with aortic 
valve disease (stenosis [Group IlIa] or regurgitation [Group IlIb]); Group IV = patients with coronary artery disease; 
HCM = hypertrophic cardiomyopathy; L VEDP = left ventricular end-diastolic pressure; LVSP = left ventricular 
peak systolic pressure; PAP mean = mean pulmonary pressure. 
VvMF = [(100% - VvINT)' VvIMF]/IOO, 
where V vMF represents the volume fraction of myofibrils in 
relation to the total myocardium, V vINT denotes the vol-
ume fraction of interstitial fibrosis and V vIMF denotes the 
intracellular volume fraction of myofibrils. 
To validate results of light microscopic morphometry, 50 
of the current serial sections were counted simultaneously 
by light and electron microscopy. Linear regression analysis 
revealed a strong correlation of the morphometric data 
derived from either technique (n = 50, r = 0.90, p < 0.001) 
with slight overestimation of the myofibrillar volume fraction 
by light microscopy (+2.7 vol% on average). 
The control data for the volume fraction of interstitial 
fibrosis, the fiber diameter and the intracellular volume 
fraction of myofibrils were obtained from transmural biopsy 
specimens taken from normal donor hearts at the time of 
heart transplantation (control group). 
Statistical analysis. Continuous data are presented as 
mean value ± 1 SD. Statistical analysis was performed by 
using analysis of variance followed by the Bonferroni t test. 
Significance was accepted at the 0.05 probability level. 
Multiple logistic regression analysis was performed to 
test the effect of independent (binary or scalar) variables on 
a binary dependent variable (16). In the present study, the 
dependent variable was normal or impaired left ventricular 
function, and impaired regional wall motion in patients with 
coronary heart disease, respectively. A binary dependent 
variable was used because left ventricular function was 
assessed by two different methods (global ejection fraction in 
Groups I to III and regional wall motion in Group IV). 
The independent variables encompassed the morphomet-
ric parameters (fiber diameter, volume density of myo-
fibrils), the clinical diagnoses and the patients' gender and 
age. The clinical diagnoses and the patients' gender were 
binary variables, the morphometric data and the patients' 
age were scalar variables. 
The mUltiple logistic regression analysis was performed 
using the procedure "LR" (stepwise logistic regression) of 
the BMDP statistical package (BMDP Statistical Software 
1988). 
Results 
The hemodynamic data of the 124 patients are listed in 
Table 1 and the morphometric data of the 130 biopsy 
specimens evaluated in Table 2. 
In contrast to patients with dilated cardiomyopathy (Fig. 
I), hypertrophic cardiomyopathy (Fig. 2) and coronary heart 
disease, patients with aortic valve disease (Fig. 3) had a 
significantly decreased volume fraction of myofibrils (p < 
0.05). Myocardial hypertrophy was most pronounced in 
patients with aortic valve disease (p < 0.05 vs. control 
values). In patients with dilated cardiomyopathy, aortic 
valve disease and coronary heart disease (Fig. 4 and 5), the 
volume fraction of interstitial tissue was significantly in-
creased (p < 0.05 vs. control values). 
MUltiple logistic regression analysis (Table 3), revealed 
increased mean fiber diameter (p < 0.002) and decreased 
volume fraction of myofibrils (p < 0.005) as significant 
independent determinants of impaired left ventricular func-
tion. These variables were predictive independent of both 
the underlying heart disease and the patients' gender and 
age. 
Discussion 
Multiple interactions between myocardial structure and 
cardiac performance have to be anticipated (10). In the 
present study, multiple logistic regression analysis revealed 
increased mean fiber diameter and loss of myofibrils as 
significant independent determinants of impaired left ven-
tricular function. 
Both interstitial and reparative cardiac fibrosis are com-
monly observed in patients with chronic heart diseases (15). 
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Table 2. Morphometric Data Obtained in the 124 Study Patients (mean::+:: I SD) 
Fiber 
Clinical VviNT Diameter VvlMF VvMF 
Patient Group No. Diagnosis (vol'7c) (,urn) (vol%) (vol%) 
la 40 DCM 26.5 ± 15.8* 28.2 ± 1 53.6±3.1 40.8±3.1* 
Ib 17 13.5 ± 5.4 24.2 ± 5.0 59.5 ± 3.4 51.4 ± 5.6 
II 15 HCM 11.8 ± 3.2 26.9 :!: 3.0 53.4 ± 2.0 47.0 ± 2.9 
lila 20 AS 27.9 ± 6.4' 30.5 ± 4.~* 57 .7 :!: 5.9 40.7 ± 4.2* 
lllb 12 AR 30.9 ± 4.9* 31.8 :!: 3.2* 56.6 ± 4.6 39.2 ± 4.9' 
IV 20 CADt 43.7 ± 7.9' 26.6 ± 5.2 52.7 ± 4.5* 29.7 ± 5.6* 
Control group+ 6 10.3 ± 2.2 22.6 ± 2.4 58.6 ± 3.5 52.5 ± 4.7 
*p < 0.05 versus values in control group (normal donor hearts). CData obtained from transmural biopsy 
specimens from the anterior left ventricular wall. :i:Data obtained from transmural left ventricular biopsy specimens 
from normal donor hearts. V vlMF = intracellular volume fraction of myofibrils: V viNT = volume fraction of fibrous 
tissue: VvMF = volume fraction of myofibrils: definition of groups and other abbreviations as in Table 1. 
Interstitial fibrosis is thereby characterized as intermyocar-
diocytic fibrosis in the absence of myocyte necrosis. In 
hemodynamically overloaded or dilated hearts, collagen 
synthesis may be stimulated either directly by increased wall 
stress or indirectly by neural or endocrine activation (17,18). 
Conversely, reparative (that is, replacement) fibrosis results 
from myocyte necrosis, which also may be caused by 
infectious or toxic damage as well as by microcirculatory 
disturbances (19-22). 
Increased interstitial fibrosis leads to fibrotic sheets be-
tween capillaries and myocytes, which may cause an inhibi-
tion of the transcapillary exchange. Thus, secondary fiber 
atrophy and even necrosis could be induced by primary 
interstitial alterations. 
A1yocyte degeneration with reduction of contractile pro-
teins is generally considered a nonspecific phenomenon in 
failing hearts 1). The molecular mechanisms of impaired 
synthesis or enhanced degradation of contractile proteins are 
not exactly elucidated. As a hypothesis, persistent systolic 
overload at the myofibrillar level may be assumed to induce 
degenerative alterations of the myocytes (12), thereby fur-
ther enhancing the vicious cycle of myofibrillar overload, 
myocyte degeneration and cardiac fibrosis (23,24). 
Both cardiac fibrosis and myocyte degeneration with loss 
of myofibrils decrease the myofibrillar area per unit trans-
verse sectional area, thereby lowering the cardiac contractile 
force (4,11,25). The present study data demonstrate that in 
different chronic cardiac diseases, such as dilated cardiomy-
opathy, hypertrophic cardiomyopathy, aortic valve disease 
and coronary heart disease, the decreased volume density of 
myofibrils is an independent determinant of impaired left 
ventricular function. 
Myocyte hypertrophy is assumed to result from parallel 
apposition of new myofibrils (12); it usually follows chronic 
Figure 1. Dilated cardiomyopathy 
(Group Ia): loss of myofibrils and 
moderate hypertrophy of the muscle 
fibers (semithin section; light micro-
graph; original magnification x 1,200, 
reduced by 30o/c.). 
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Figure 2. Hypertrophic cardiomyopathy 
(Group myocyte hypertrophy and 
slightly reduced intracellular content of 
myofibrils (semi thin section; light micro-
graph; original magnification x 1.200, re-
duced by 
mechanical overloading of the heart and is therefore a 
common observation in several chronic cardiac disorders 
(26,27). As shown in Table 1, myofiber hypertrophy is most 
pronounced in patients with aortic valve disease and coro-
nary heart disease (Groups III and IV). 
In patients with aortic valve disease (Group pressure 
or volume overload hypertrophy, or both, is associated with 
myocardial areas offocal necrosis, resulting in a significantly 
(p < 0.05) increased volume fraction of fibrous tissue (Table 
2). Yet it remains unclear "vhether the myocytes become 
hypertrophic in response to the increased work load or in 
compensation for the loss of contractile material (27). In 
Figure 3. Aortic stenosis (Group IlIa); 
myocyte hypertrophy and almost normal 
content of contractile material (semithin 
section; light micrograph; original magni-
fication x \,200, reduced by 30%). 
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patients with coronary heart disease (Group IV), hypertro-
phy of surviving muscle cells is most likely a compensatory 
process for the increased work load that follows the loss of 
myocardial mass as a result of myocardial cell death and scar 
formation (28). In a recent study using serial echocardiog-
raphy (29), it was demonstrated that the left ventricular mass 
of noninfarcted myocardium increases in relation to the 
increase in left ventricular function after myocardial infarc-
tion. 
Possible initiating signals for myofiber hypertrophy in-
clude mechanical stretch, cell deformation and the permis-
sive or direct effect of neurotransmitters and hormones such 
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as adrenergic agonists, thyroxine or angiotensin II (27). In 
hypertensive hearts, for example, diminution of cyclic aden-
osine monophosphate (probably due to activation of cyclic 
adenosine monophosphate phosphodiesterase activity) and 
stimulation of alphar receptors have been postulated as 
possible stimuli for the development of myofiber hypertro-
phy (30). 
Myocyte degeneration and severe hypertrophy are fre-
quently associated in failing hearts (3). However, the present 
data indicate that myocyte hypertrophy represents another 
lACC Vol. 20. No.5 
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Figure 4. Coronary artery disease 
(Group IV): increased amount of inter-
stitial fibrosis scarring) with atro-
phic myocytes (semithin section; light 
micrograph; original magnification 
x ,200, reduced by 30%). 
determinant of left ventricular dysfunction that is indepen-
dent of myocyte degeneration and cardiac fibrosis. 
Methodologic considerations. Assessment of the myo-
fibrillar volume fraction with the use oflight microscopy was 
introduced earlier by our group (1 Light microscopy 
permits analysis of larger test areas than can be analyzed 
with electron microscopy. To further validate light micro-
scopic morphometry on the basis of a larger number of 
cases, 50 of the current serial sections were counted simul-
taneously both light and electron microscopy. Linear 
Figure 5. Coronary heart disease 
(Group IV): excessive loss of myo-
fibrils and increased fibrosis (semithin 
section; light micrograph; original 
magnification x 1,200, reduced by 
30%). 
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Table 3. Results Derived From Multiple Logistic Regression 
Analysis With (Normal or Impaired) Left Ventricular Function as 
Dependent Variable 
Independent Variables 
Fiber diameter 
VvMF 
Gender 
Age 
Group I 
Group II 
Group IlIa 
Group IIIb 
Group IV 
Definition of groups and abbreviations as in Tables I and 2. 
p Value 
<0.002 
<0.005 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
regression analysis revealed a strong correlation of the 
morphometric data derived from either technique. These 
data confirm the earlier published results from our group (II) 
obtained in a smaller (n = 12) group of patients. 
Limitations of the study. First, morphometric data were 
obtained from endomyocardial (Groups I to III) and trans-
mural biopsy specimens (Group IV). However, wall stress 
and myocardial oxygen demand are greater in endomyocar-
dial segments, and structural alterations may therefore be 
more pronounced in endocardial than in epicardial segments. 
This observation should be taken into account with respect 
to the morphometric data in the different subgroups of 
patients (Table I). 
Second, because structural alterations are quite uni-
formly distributed over the ventricle in Groups I to III, two 
to four left ventricular biopsy specimens should be adequate 
to determine the variation in the morphometric variables 
tested (11,12,31). Despite a low sampling error obtained with 
Travenol biopsy needles in autopsy hearts (28), the consid-
erably more inhomogeneous distribution of structural alter-
ations in coronary heart disease might increase the sampling 
error in the morphometric data derived from Group IV 
patients. However, analysis of the morphometric data from 
Group IV patients with or without previous myocardial 
infarction revealed significant differences with respect to 
cardiac fibrosis (p < 0.02), myofibrillar density (p < 0.05) 
and myofiber diameter (p < 0.05); these results may further 
indicate a tolerable sampling error in the morphometric data 
of Group IV. . 
Third, in the present study, left ventricular (systolic) 
function was assessed from cineventriculograms by measur-
ing globall~ft ventricular ejection fraction (Groups I to III) 
or regional anterior wall motion (Group IV). However, both 
left ventricular ejection fraction and regional wall motion are 
modulated by several factors, including actual preload, 
afterload and heart rate during catheterization. In addition, 
these loading conditions are markedly altered in the diverse 
disease states investigated. 
Conclusions. As determined by multiple logistic regres-
sion analysis based on 130 left ventricular biopsy specimens, 
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the present study data delineate decreased volume density of 
myofibrils and myofiber hypertrophy as independent deter-
minants of impaired left ventricular function. Thus, indepen-
dent of the underlying diseases and the patients' gender and 
age, loss of myofibrils (from both myofiber degeneration and 
fibrosis) is associated with impaired left ventricular function. 
Furthermore, the present data indicate that in chronic heart 
diseases, myocyte hypertrophy itself is pathologic-
independent of myocyte degeneration and cardiac fibrosis. 
These results, however, do not establish cause and effect. 
We are indebted to Hans Scheurlen, MD and Rolf Spitzer, Institute for 
Medical Biometry, University of Heidelberg, for expert statistical advice, and 
to Winfried Nottmeyer, Institute of Pathology, University of Heidelberg, for 
excellent technical assistance. 
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